Number of the records: 1
Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases
- Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases / Matúšková, M. ... [et al.] . Journal of experimental & clinical cancer research : CR . - Vol. 34, no. 1 (2015), s. 33 [Dokument nie je vo fonde knižnice]
article
Number of the records: 1